Run domain Beclin-1-interacting and cysteine-rich domain-containing protein (RUBCN)

Rubicon autophagy regulator (RUBCN) is a multi-domain protein encoded by the RUBCN gene, characterized by an N-terminal RUN domain and a C-terminal cysteine-rich Rubicon homology (RH) domain[3][5]. RUBCN acts as a potent negative regulator of autophagy by inhibiting autophagosome maturation and fusion with lysosomes, primarily through interaction with Beclin-1 and the class III PI3K complex (PI3KC3)[2][3]. It also controls endocytic trafficking and is critical in LC3-associated phagocytosis and endocytosis[2][3][5]. RUBCN has context-dependent roles, with alternative splicing resulting in isoforms that have opposing activities in autophagy and immune cell differentiation[1][4]. Elevated RUBCN is implicated in metabolic diseases, aging, neurodegeneration, and some cancers, making it a potential therapeutic target[2][3]. There are no currently approved drugs that directly target RUBCN; research is ongoing to develop inhibitors or approaches to modulate its function for clinical benefit[2]. Dysfunction or mutation in RUBCN can result in neurological disorders such as recessive ataxia[5].

Other names

RubiconKIAA0226SCAR15RUBICONrundataxinBaronBeclin-1 associated RUN domain containing proteinRUN and cysteine rich domain containing beclin 1 interacting protein

Inhibition of RUBCN function (e.g., RNAi, gene knockout) activates autophagy and mitigates disease features such as steatosis, fibrosis, and neurodegeneration[2][3].